scholarly article | Q13442814 |
P356 | DOI | 10.1007/S00268-017-4400-1 |
P698 | PubMed publication ID | 29270656 |
P2093 | author name string | Hiroaki Saito | |
Yuji Shishido | |||
Yoshiyuki Fujiwara | |||
Tomohiro Osaki | |||
Tomoyuki Matsunaga | |||
Yusuke Kono | |||
Yoji Fukumoto | |||
Yuki Murakami | |||
Hirohiko Kuroda | |||
Keigo Ashida | |||
P2860 | cites work | Global cancer statistics | Q22241238 |
Inflammation and cancer | Q24649640 | ||
Glasgow Prognostic Score (GPS) can be a useful indicator to determine prognosis of patients with colorectal carcinoma | Q34621908 | ||
C-reactive protein/albumin ratio predicts 90-day mortality of septic patients | Q34648986 | ||
The neutrophil-lymphocyte ratio and its utilisation for the management of cancer patients in early clinical trials. | Q35274955 | ||
A Novel Inflammation-Based Prognostic Score, the C-Reactive Protein/Albumin Ratio Predicts the Prognosis of Patients with Operable Esophageal Squamous Cell Carcinoma | Q35781911 | ||
Comparison of the prognostic value of inflammation-based prognostic scores in patients with hepatocellular carcinoma | Q36299107 | ||
Overview of the MNA--Its history and challenges | Q36689850 | ||
Increased neutrophil-lymphocyte ratio is a poor prognostic factor in patients with primary operable and inoperable pancreatic cancer. | Q37040624 | ||
C-reactive protein in liver cancer surgery | Q37115036 | ||
Evaluation of a modified early warning system for acute medical admissions and comparison with C-reactive protein/albumin ratio as a predictor of patient outcome. | Q39996624 | ||
Evaluation of Modified Glasgow Prognostic Score for Pancreatic Cancer: A Retrospective Cohort Study. | Q40399233 | ||
Preoperative neutrophil-to-lymphocyte ratio is a prognostic factor for overall survival in patients with gastric cancer | Q40666754 | ||
A multifactorial approach for the prognosis of patients with carcinoma of the stomach after curative resection | Q44132933 | ||
Prognostic value of neutrophil-lymphocyte ratio and level of C-reactive protein in a large cohort of pancreatic cancer patients: a retrospective study in a single institute in Japan | Q44317521 | ||
Prognostic significance of the modified Glasgow prognostic score in elderly patients with gastric cancer | Q45775833 | ||
Prognostic value of early postoperative tumor marker response in gastric cancer. | Q45927588 | ||
Nutritional risk screening (NRS 2002): a new method based on an analysis of controlled clinical trials | Q47889830 | ||
Systemic inflammation is associated with the density of immune cells in the tumor microenvironment of gastric cancer. | Q48336799 | ||
Prognostic Value of the CRP/Alb Ratio, a Novel Inflammation-Based Score in Pancreatic Cancer. | Q51482020 | ||
Prognostic role of C-reactive protein in gastric cancer: a meta-analysis. | Q54514438 | ||
Clinical characteristics and outcomes for gastric cancer patients aged 18–30 years | Q56906393 | ||
What is subjective global assessment of nutritional status? | Q69758169 | ||
[Prognostic nutritional index in gastrointestinal surgery of malnourished cancer patients] | Q70507813 | ||
Japanese classification of gastric carcinoma: 3rd English edition | Q84106763 | ||
Significance of modified Glasgow prognostic score as a useful indicator for prognosis of patients with gastric carcinoma | Q85013632 | ||
The C-reactive protein/albumin ratio, a novel inflammation-based prognostic score, predicts outcomes in patients with hepatocellular carcinoma | Q85252932 | ||
The C-reactive Protein to Albumin Ratio Predicts Long-Term Outcomes in Patients with Pancreatic Cancer After Pancreatic Resection | Q87422926 | ||
P577 | publication date | 2017-12-21 | |
P1433 | published in | World Journal of Surgery | Q15763279 |
P1476 | title | Prognostic Significance of the Preoperative Ratio of C-Reactive Protein to Albumin and Neutrophil-Lymphocyte Ratio in Gastric Cancer Patients |
Q58095171 | CRP/prealbumin, a novel inflammatory index for predicting recurrence after radical resection in gastric cancer patients: post hoc analysis of a randomized phase III trial |
Q91728315 | Clinical significance of neutrophil-to-lymphocyte ratio as a predictor of lymph node metastasis in gastric cancer |
Q92697443 | Clinical significance of systemic immune-inflammation index (SII) and C-reactive protein-to-albumin ratio (CAR) in patients with esophageal cancer: a meta-analysis |
Q94527007 | Evaluation of the value of multiparameter combined analysis of serum markers in the early diagnosis of gastric cancer |
Q91875938 | High C-Reactive Protein to Albumin Ratio Predicts Inferior Clinical Outcomes in Extranodal Natural Killer T-Cell Lymphoma |
Q64922740 | Low Preoperative Lymphocyte to Monocyte Ratio Serves as a Worse Prognostic Marker in Patients with Esophageal Squamous Cell Carcinoma Undergoing Curative Tumor Resection. |
Q90157642 | Prognostic role of the pretreatment C-reactive protein/albumin ratio in gastric cancer: A systematic review and meta-analysis |
Q92659036 | Prognostic significance of the CRP/Alb and neutrophil to lymphocyte ratios in hepatocellular carcinoma patients undergoing TACE and RFA |
Q57294711 | The C-Reactive Protein/Albumin Ratio as a Predictor of Mortality in Critically Ill Patients |
Search more.